2020
DOI: 10.1016/j.jacc.2020.01.046
|View full text |Cite
|
Sign up to set email alerts
|

Wearable Devices for Ambulatory Cardiac Monitoring

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
146
0
3

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 199 publications
(151 citation statements)
references
References 47 publications
0
146
0
3
Order By: Relevance
“…As an example, electrophysiologists have been converting most clinical visits to remote monitoring (phone, video calls for visits, review of data from digital wearables, etc.) [ 9 , 10 ], as well as cardiac implantable electronic device checks, whenever feasible [ 11 ], as suggested as class I recommendation [ 12 ]. Where possible, nonurgent procedures should be postponed or, in the case of need, coordinated on the same day of visit to minimize multiple exposures, whilst postprocedural follow-up should be performed remotely.…”
Section: The Importance Of Telemedicine In a Pandemicmentioning
confidence: 99%
“…As an example, electrophysiologists have been converting most clinical visits to remote monitoring (phone, video calls for visits, review of data from digital wearables, etc.) [ 9 , 10 ], as well as cardiac implantable electronic device checks, whenever feasible [ 11 ], as suggested as class I recommendation [ 12 ]. Where possible, nonurgent procedures should be postponed or, in the case of need, coordinated on the same day of visit to minimize multiple exposures, whilst postprocedural follow-up should be performed remotely.…”
Section: The Importance Of Telemedicine In a Pandemicmentioning
confidence: 99%
“…Today it is possible to remotely monitor cardiac rhythm and vital signs continuously on the hospital wards, where close nursing observation is not always possible. [32][33][34] Given the importance of treating diabetes and uncontrolled hyperglycemia in every unit of the hospital, and the improvements in performance of currentgeneration CGM systems, we say why not continuously measure glucose in the hospital as well? The appropriate implementation of this technology may significantly decrease the burden of glucose monitoring for patients and providers.…”
Section: Discussionmentioning
confidence: 99%
“…Many of these technologies are also being explored for various scenarios in cardiology (44)(45)(46)(47)(48)(49)(50)(51), and have great clinical utility for cardio-oncology and COVID-19. Remote monitoring from wearable biosensors and mHealth is being investigated to improve outcomes in heart rhythm and heart failure and other cardiovascular conditions (44,(46)(47)(48)(49)(50), and may have utility for COVID-19 (19,(52)(53)(54)(55)(56)(57)(58) and Cardio-Oncology (59)(60)(61). Voice apps and voice analysis have shown promise in cardiology for heart failure, ischemic heart disease, pulmonary hypertension, and other forms of cardiovascular disease (45,(62)(63)(64), as well as cardio-oncology (65), and have been considered for COVID-19.…”
Section: Innovation Beyond the Pandemic Artificial Intelligencementioning
confidence: 99%
“…All of these components can be useful in both the COVID-19 pandemic and the practice of Cardio-Oncology. Many of these technologies are also being explored for various scenarios in cardiology ( 44 51 ), and have great clinical utility for cardio-oncology and COVID-19. Remote monitoring from wearable biosensors and mHealth is being investigated to improve outcomes in heart rhythm and heart failure and other cardiovascular conditions ( 44 , 46 50 ), and may have utility for COVID-19 ( 19 , 52 58 ) and Cardio-Oncology ( 59 61 ).…”
Section: Innovation Beyond the Pandemicmentioning
confidence: 99%